CRISPR and Microfluidics Work Together to Detect Ebola | AIChE

CRISPR and Microfluidics Work Together to Detect Ebola


Epidemics of disease caused by highly infectious pathogens are particularly devastating in developing countries with limited laboratory infrastructure and trained medical staff.

The 2014 Ebola epidemic began with a series of patients misdiagnosed with malaria and typhoid fever. Health officials, suspicious of the spate of cases, sent blood samples to European laboratories for analysis — three months after the initial outbreak, tests confirmed the disease as Ebola...

Would you like to access the complete CEP News Update?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.

Related Topics